Range
3.56 - 3.73
Vol / Avg.
8.6M/3.7M
Div / Yield
-
52 Wk
2.09 - 13.71
Mkt Cap
589.2M
Payout Ratio
-
Open
3.65
P/E
-
EPS
-0.45
Shares
160.1M
Outstanding
160.1M
Total Float
136.1M
load more
Sector: Health Care.Industry: Biotechnology
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.360-0.450 -0.0900
REV42.840M52.304M9.464M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AKBAAkebia Therapeutics0.27%589.2M

Akebia Therapeutics Frequently Asked Questions

Q

How do I buy Akebia Therapeutics (AKBA) stock?

A

You can purchase shares of Akebia Therapeutics (NASDAQ: AKBA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Akebia Therapeutics's (AKBA) competitors?

Q

What is the target price for Akebia Therapeutics (AKBA) stock?

A

The latest price target for Akebia Therapeutics (NASDAQ: AKBA) was reported by Cantor Fitzgerald on March 8, 2021. The analyst firm set a price target for 8.00 expecting AKBA to rise to within 12 months (a possible 117.39% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Akebia Therapeutics (AKBA)?

A

The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $3.68 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Akebia Therapeutics (AKBA) pay a dividend?

A

There are no upcoming dividends for Akebia Therapeutics.

Q

When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?

A
Akebia Therapeutics’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Akebia Therapeutics (AKBA) going to split?

A

There is no upcoming split for Akebia Therapeutics.

Q

What sector and industry does Akebia Therapeutics (AKBA) operate in?

A

Akebia Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.